Cover Image
市場調查報告書

中國的醫院產業:2015年∼2018年

China Hospital Industry Report,2016-2020

出版商 ResearchInChina 商品編碼 272314
出版日期 內容資訊 英文 141 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的醫院產業:2015年∼2018年 China Hospital Industry Report,2016-2020
出版日期: 2017年01月16日 內容資訊: 英文 141 Pages
簡介

中國的醫院數,由於需求推動,從2011年的21,979到2015年5月末的26,479,整體增加了4,500。明細中,公立醫院整體減少,私立醫院劇增。2011年∼2015年5月末之間,私立醫院數為4,713,佔有率從38.4%增加到49.7%。但,在收益方面,中國的私立醫院只佔10%。

本報告提供中國的醫院產業調查分析、產業概要、專門醫院現況、產業的發展預測、投資相關驗證、主要醫院簡介等系統性資訊。

第1章 中國的醫院產業概要

  • 定義
  • 分類
  • 產業鏈

第2章 中國的醫院產業的發展

  • 概要
  • 收益
  • 醫療服務
  • 競爭格局
  • 摘要與預測

第3章 中國的專門醫院的發展

  • 概要
  • 各種專門醫院現況

第4章 中國的醫院產業的發展預測

  • 中國的醫療保險現況
  • 都市化的醫院產業的發展

第5章 中國的醫院產業的投資

  • 政策的推動力
  • 公立醫院 vs. 私立醫院
  • 社會資本的投資機會
  • 外資醫院發展的方向性與經營模式

第6章 中國的主要私立醫院

  • 簡介、經營、收益結構、毛利等
    • Aier Eye Hospital Group
    • TC Medical
    • Mayinglong Pharm
    • Shanghai Fosun Pharmaceutical (Group)
    • Jinling Pharmaceutical Company Limited
    • Shinva Medical
    • Xi'an International Medical Investment Co., Ltd.
    • Inner Mongolia Furui Medical Science
    • Wuhan Jianmin Pharmaceutical Groups Corp.
    • Concord Medical Services Holdings Limited
    • Phoenix Healthcare Group
    • Guizhou Yibai Pharmaceutical
    • Kangmei Pharmaceutica
    • JNMPT
    • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
    • Parkway Pantai

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ZLC043

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people's growing awareness of health care and the acceleration of population aging have prompted the rapid development of China's hospital industry. As of October 2016, there had been a total of 28,584 hospitals in China, an increase of 7,666 compared with that in 2010. It is estimated that Chinese hospitals gained the revenue of RMB2,708 billion in 2016, soaring 163.3% over 2010.

Chinese medical insurance system has been gradually perfect and medical resources have swelled radically, laying the foundation for the healthy and orderly development of the hospital industry. As of the end of 2015, a total of 666 million Chinese people had enjoyed urban basic medical insurance and 670 million people had held new rural cooperative medical insurance, marking the full coverage of medical insurance. At the same time, the national medical and health institutions had offered 7.015 million beds, namely 5.11 beds for per thousand population. According to Circular on Accelerating the Construction of Health and Old-age Service Project, medical and health institutions should provide 6 beds for per thousand population (including inpatients) averagely by 2020.

Driven by the reform of public hospitals and other policies, China has set off a wave of social capital inrush to the medical industry and witnessed an upsurge in the number of private hospitals. By the end of October 2016, there had been 15,798 private hospitals in China, accounting for 55.3% of the total hospitals. However, the revenue of private hospitals is less than 10% of the total hospital revenue. In the forthcoming years, Chinese private hospitals will grow by leaps and bounds, with the number registering 20,262 and the revenue reporting RMB639.6 billion by 2020.

Specialized hospitals need low investment costs but trigger high return on investment; coupled with the robust demand, they have attracted the fanatical investment of social capital. Private hospitals occupy more than 65% of Chinese specialized hospitals. In recent years, the revenue of Chinese specialized hospitals has been growing at around 20%; the current revenue exceeds RMB300 billion.

Among specialized hospitals, ophthalmic hospitals, stomatological hospitals as well as orthopedics & beauty hospitals enjoy exceedingly high profitability, with the profit margin of above 10%. For instance, Aier Eye Hospital, the nation's largest chain ophthalmic institution - boasts over 100 stores in the country and serves more than 3 million outpatients annually; in the first half of 2016, the company achieved the revenue of RMB1.92 billion, the net income of RMB280 million and the net profit margin of 14.6%.

The report highlights the following:

  • Overview of China hospital industry, including number of hospitals, revenue, medical services, competition pattern, forecast and prospect, etc.;
  • Status quo of specialized hospitals in China, including overview, analysis on specialized hospitals of all sorts, summary and forecast;
  • Overview of Chinese medical insurance system, embracing status quo and development trend;
  • Investment in China hospital industry, including related policies, comparison between public and private hospitals, investment of social capital, development directions and business models of foreign-funded hospitals;
  • Operation, hospital industry layout, development forecast, etc. of 15 enterprises.

Table of Contents

1. Overview of China Hospital Industry

  • 1.1. Definition
  • 1.2. Classification
  • 1.3. Industry Chain

2. Development of China Hospital Industry

  • 2.1. Overview
    • 2.1.1. Number of Hospitals
    • 2.1.2. Distribution
  • 2.2. Revenue
  • 2.3. Medical Services
    • 2.3.1. Patient Visits
    • 2.3.2. Bed Utilization
  • 2.4. Competition Pattern
  • 2.5. Forecast and Prospect
    • 2.5.1. Number and Revenue of Hospitals Will Grow Steadily
    • 2.5.2. Public-private Partnership of Hospitals Becomes a General Trend
    • 2.5.3. Number and Revenue of Private Hospitals Will See Steady Growth
    • 2.5.4. Private Hospitals Tend to Be Professional
    • 2.5.5. Private Hospitals Will Forge Brands Gradually

3. Development of Specialized Hospitals in China

  • 3.1. Overview
    • 3.1.1. Number of Specialized Hospitals
    • 3.1.2. Revenue
  • 3.2. Status Quo of Specialized Hospitals of All Kinds
    • 3.2.1. Ophthalmic Hospital
    • 3.2.2. Stomatological Hospital
    • 3.2.3. Orthopedics & Beauty Hospital
    • 3.2.4. Obstetrics & Gynecology Hospital
    • 3.2.5. Children's Hospital
    • 3.2.6. Tumor Hospital
  • 3.3. Summary and Forecast

4. Development of Chinese Medical Insurance System

  • 4.1. Status Quo
    • 4.1.1. Medical Insurance System
    • 4.1.2. Coverage of Medical Insurance System Is Close to Saturation
    • 4.1.3. Serious Illness Insurance for Urban and Rural Residents
  • 4.2. Development Trends
    • 4.2.1. Urbanization Will Optimize Health Care System
    • 4.2.2. Trans-regional Medical Insurance Settlement Will Be Promoted
    • 4.2.3. Accumulated Balance of Medical Insurance Funds Grows Year by Year
    • 4.2.4. Medical Resource Supply Capacity of County-level Hospitals Will Improve
    • 4.2.5. Medical Resources Will Grow Rapidly

5. Investment in China Hospital Industry

  • 5.1. Policies
  • 5.2. Comparison between Public and Private Hospitals
    • 5.2.1. Public Hospitals Play a Leading Role
    • 5.2.2. Private Hospitals Run with High Efficiency
  • 5.3. Investment Fields of Social Capital
    • 5.3.1. Specialized Medical Field
    • 5.3.2. General Public Hospitals
  • 5.4. Development Orientation and Business Model of Foreign Hospitals
    • 5.4.1. Status Quo of Foreign Hospitals in China
    • 5.4.2. Development Direction
    • 5.4.3. Business Practice

6. Major Enterprises

  • 6.1. Aier Eye Hospital Group
    • 6.1.1. Profile
    • 6.1.2. Operation
    • 6.1.3. Revenue Structure
    • 6.1.4. Gross Margin
    • 6.1.5. R&D and Investment
    • 6.1.6. Medical Services
    • 6.1.7. Prediction
  • 6.2. TC Medical
    • 6.2.1. Profile
    • 6.2.2. Operation
    • 6.2.3. Revenue Structure
    • 6.2.4. Gross Margin
    • 6.2.5. Medical Services
    • 6.2.6. Prediction
  • 6.3. Mayinglong Pharm
    • 6.3.1. Profile
    • 6.3.2. Operation
    • 6.3.3. Revenue Structure
    • 6.3.4. Gross Margin
    • 6.3.5. R&D
    • 6.3.6. Medical Services
    • 6.3.7. Prediction and Outlook
  • 6.4. Shanghai Fosun Pharmaceutical (Group)
    • 6.4.1. Profile
    • 6.4.2. Operation
    • 6.4.3. Revenue Structure
    • 6.4.4. Gross Margin
    • 6.4.5. R&D and Investment
    • 6.4.6. Medical Services
    • 6.4.7. Prediction and Outlook
  • 6.5. Jinling Pharmaceutical Company Limited
    • 6.5.1. Profile
    • 6.5.2. Operation
    • 6.5.3. Revenue Structure
    • 6.5.4. Gross Margin
    • 6.5.5. R&D and Investment
    • 6.5.6. Medical Services
    • 6.5.7. Prediction and Outlook
  • 6.6. Shinva Medical Instrument
    • 6.6.1. Profile
    • 6.6.2. Operation
    • 6.6.3. Revenue Structure
    • 6.6.4. Gross Margin
    • 6.6.5. R&D and Investment
    • 6.6.6. Medical Services
    • 6.6.7. Prediction and Outlook
  • 6.7. Xi'an International Medical Investment Co., Ltd.
    • 6.7.1. Profile
    • 6.7.2. Operation
    • 6.7.3. Revenue Structure
    • 6.7.4. Medical Services
    • 6.7.5. Prediction and Outlook
  • 6.8. Inner Mongolia Furui Medical Science
    • 6.8.1. Profile
    • 6.8.2. Operation
    • 6.8.3. Revenue Structure
    • 6.8.4. Medical Services
    • 6.8.5. Prediction and Outlook
  • 6.9. Wuhan Jianmin Pharmaceutical Groups Corp.
    • 6.9.1. Profile
    • 6.9.2. Operation
    • 6.9.3. Revenue Structure
    • 6.9.4. Medical Services
    • 6.9.5. Prediction and Outlook
  • 6.10. Concord Medical Services Holdings Limited
    • 6.10.1. Profile
    • 6.10.2. Operation
    • 6.10.3. Medical Services
    • 6.10.4. Prediction and Outlook
  • 6.11. Phoenix Healthcare Group
    • 6.11.1. Profile
    • 6.11.2. Operation
    • 6.11.3. Medical Services
    • 6.11.4. Prediction and Outlook
  • 6.12. Guizhou Yibai Pharmaceutical
    • 6.12.1. Profile
    • 6.12.2. Operation
    • 6.12.3. Medical Services
    • 6.12.4. Prediction and Outlook
  • 6.13. Kangmei Pharmaceutical
    • 6.13.1. Profile
    • 6.13.2. Operation
    • 6.13.3. Medical Services
    • 6.13.4. Prediction and Outlook
  • 6.14. Jiangnan Mould & Plastic Technology
    • 6.14.1. Profile
    • 6.14.2. Operation
    • 6.14.3. Medical Services
    • 6.14.4. Prediction and Outlook
  • 6.15. Beijing Meizhong Jiahe Hospital Management
    • 6.15.1. Profile
    • 6.15.2. Operation
    • 6.15.3. Major Clients
    • 6.15.4. Medical Services
    • 6.15.5. Prediction and Outlook

Selected Charts:

  • Types and Introduction of Hospitals in China
  • Hospital Industry Chain in China
  • Number and YoY Growth of Hospitals in China, 2009-2016
  • Number of Hospitals in China by Hospital Level, 2009-2016
  • Percentage of Hospitals in China by Hospital Level, 2009-2016
  • Number of Hospitals in China by Economic Type, 2009-2016
  • Percentage of Hospitals in China by Economic Type, 2009-2016
  • Number of Hospitals in China by Type, 2009-2016
  • Number of Hospitals in China by Region as of Sept. 2016
  • Total Revenue of Hospitals in China, 2009-2016
  • Revenue Structure of Hospitals in China by Source, 2016
  • Revenue Structure of Hospitals in China by Hospital Type, 2016
  • Outpatient Visits to Hospitals in China, 2009-2016
  • Outpatient Visits to Hospitals in China by Economic Type, 2012-2016
  • Structure of Outpatient Visits to Hospitals in China by Economic Type, 2012-2016
  • Outpatient Visits to Hospitals in China by Hospital Type, 2012-2016
  • Structure of Outpatient Visits to Hospitals in China by Hospital Level, 2012-2016
  • Utilization of Hospital Beds in China, 2009-2016
  • Utilization of Hospital Beds in China by Hospital Level, 2009-2016
  • Proportion of Public Medical Institutions and Private Hospitals in China by Type, 2016
  • Medical Service Revenue of Major Private Hospitals in China, 2012-2016
  • Number and YoY Growth of Hospitals in China, 2015-2020E
  • Revenue and YoY Growth Rate of Hospitals in China, 2015-2020E
  • Revenue of Hospitals in China by Economic Type, 2015-2020E
  • Number of Private Hospitals and % of Total Hospitals in China, 2009-2020E
  • Revenue of Private Hospitals and % of Total Hospital Revenue in China, 2009-2020E
  • Number of Specialized Hospitals and % of Total Hospitals in China, 2009-2016
  • Proportion of Specialized Hospitals in China by Economic Type,
  • Number of Specialized Hospitals in China by Type, 2010-2016
  • Revenue of Specialized Hospitals and % of Total Hospital Revenue in China, 2009-2016
  • Revenue of Specialized Hospitals in China by Type, 2010-2016
  • Profit Margin of Specialized Hospitals in China by Type, 2010-2016
  • Number of Ophthalmic Hospitals in China by Economic Type, 2009-2016
  • Total Revenue and Profit of Ophthalmic Hospitals in China, 2006-2016
  • Bed Utilization and Doctor Workload of Ophthalmic Hospitals in China, 2006-2016
  • Number of Stomatological Hospitals in China by Economic Type, 2009-2016
  • Total Revenue and Profit of Stomatological Hospitals in China, 2006-2016
  • Bed Utilization and Doctor Workload of Stomatological Hospitals in China, 2006-2016
  • Number and Distribution of Major Private Stomatological Medical Institutions and Their Chains in China, 2016
  • Number of Orthopedics & Beauty Hospitals in China by Economic Type, 2009-2016
  • Total Revenue and Profit of Orthopedics & Beauty Hospitals in China, 2006-2016
  • Number of Obstetrics &GynecologyHospitals in China by Economic Type, 2009-2016
  • Total Revenue and Profit of Obstetrics &Gynecology Hospitals in China, 2006-2016
  • Bed Utilization and Doctor Workload of Obstetrics &Gynecology Hospitals in China, 2006-2016
  • Number of Children's Hospitals in China by Economic Type, 2009-2016
  • Total Revenue and Profit of Children's Hospitals in China, 2009-2016
  • Bed Utilization and Doctor Workload of Children's Hospitals in China, 2009-2016
  • Number of Tumor Hospitals in China by Economic Type, 2009-2016
  • Total Revenue and Profit of Tumor Hospitals in China, 2006-2016
  • Bed Utilization and Doctor Workload of Tumor Hospitals in China, 2006-2016
  • Number of Specialized Hospitals and % of Total Hospitals in China, 2015-2020E
  • Revenue of Specialized Hospitals and % of Total Hospital Revenue in China, 2015-2020E
  • Structure of Medical Insurance System in China
  • Number of People Participating in China's Urban Resident Basic Medical Insurance by Type, 2009-2015
  • Number of People Participating in Chinas New Rural Cooperative Medical Scheme and Participation Rate, 2009-2015
  • Rate of Utilization in China, 2006-2016
  • Cumulative Balance of Medical Insurance Fund in China by Type, 2012-2015
  • Polices Supporting Construction of County-level Hospitals in China, 2009-2016
  • Number of Hospital Beds per Thousand Population in Chinese Medical and Health Institutions, 2014-2020E
  • Milestones of Social Capital Inrush to Medical Service Field in China, 1985-2016
  • Policies on Social Capital Flowing to Medical Service Field in China, 2009-2016
  • Policy Differences between Private and Public Hospitals in China
  • Principal-agent Chain of Public Hospitals in China
  • Revenue and Market Share of Public Hospitals in China, 2009-2016
  • Revenue and Market Share of Private Hospitals in China, 2009-2016
  • Comparison of Major Medical Service Items in China
  • Medical Service System Marketing Tendency in China
  • Existing Property Right System Reform Models of Public Hospitals in China
  • Cases of China's Social Capital Contributing to Public Hospital Restructuring, 1999-2016
  • Partners and Major Medical Services of Some Sino-foreign Cooperative Hospitals in China
  • Partners and Major Services of Some Foreign-led Joint Venture Hospitals in China
  • Revenue and Net Income of Aier Eye Hospital, 2011-2016
  • Revenue and Net Income of Major Subsidiaries of Aier Eye Hospital, 2015
  • Revenue Breakdown of Aier Eye Hospital by Business, 2014-2016
  • Revenue Breakdown of Aier Eye Hospital by Region, 2014-2016
  • Revenue Structure of Aier Eye Hospital by Region, 2012-2016
  • Gross Margin of Aier Eye Hospital by Business, 2014-2016
  • R&D Expenditures of Aier Eye Hospital, 2012-2016
  • Planned Investment Projects by Non-public Stock Issuance of Aier Eye Hospital, 2016
  • Acquisition Target Revenue and Net Income of Aier Eye Hospital, 2016
  • Ownership Structure of Aier Health Insurance
  • Outpatient Visits of Aier Eye Hospital, 2013-2016
  • Surgical Operations of Aier Eye Hospital, 2013-2016
  • Revenue and Net Income of Aier Eye Hospital, 2015-2020E
  • Revenue and Net Income of TC Medical, 2011-2016
  • Revenue Breakdown of TC Medical by Business, 2012-2016
  • Revenue Breakdown of TC Medical by Region, 2012-2016
  • Revenue Structure of TC Medical by Region, 2012-2016
  • Gross Margin of TC Medical, 2012-2016
  • Gross Margin of TC Medical by Business, 2012-2016
  • Revenue and Net Income of Major Subsidiaries of TC Medical, 2013-2016
  • Projects Raised by Issuing Shares of TC Medical, 2015
  • Revenue and Net Income of TC Medical, 2015-2020E
  • Revenue and Net Income of Mayinglong Pharm, 2011-2016
  • Revenue Breakdown of Mayinglong Pharm by Business, 2012-2016
  • Revenue Structure of Mayinglong Pharm by Business, 2012-2016
  • Revenue Breakdown of Mayinglong Pharm by Region, 2012-2016
  • Revenue Structure of Mayinglong Pharm by Region, 2012-2016
  • Gross Margin of Mayinglong Pharm by Business, 2012-2016
  • R&D Expenditures of Mayinglong Pharm, 2012-2016
  • R&D Investment in Major Products of Mayinglong Pharm, 2015
  • Establishment Mode and Equity Structure of Anorectal Hospitals under Mayinglong Pharm
  • Revenue and Net Income of Mayinglong Pharm, 2015-2020E
  • Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2011-2016
  • Revenue Breakdown of Shanghai Fosun Pharmaceutical by Business, 2011-2016
  • Revenue Structure of Shanghai Fosun Pharmaceutical by Business, 2011-2016
  • Revenue Breakdown of Shanghai Fosun Pharmaceutical by Region, 2011-2016
  • Revenue Structure of Shanghai Fosun Pharmaceutical by Region, 2011-2016
  • Gross Margin of Shanghai Fosun Pharmaceutical by Business, 2011-2016
  • R&D Expenditures of Shanghai Fosun Pharmaceutical, 2012-201
  • Non-public Stock Issuance and Subscription Amount of Shanghai Fosun Pharmaceutical, 2015
  • Major Controlled Hospitals of Shanghai Fosun Pharmaceutical
  • Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2015-2020E
  • Revenue and Net Income of Jinling Pharmaceutical, 2011-2016
  • Revenue Breakdown of Jinling Pharmaceutical by Business, 2011-2016
  • Revenue Structure of Jinling Pharmaceutical by Business, 2011-2016
  • Gross Margin of Jinling Pharmaceutical by Business, 2011-2016
  • R&D Expenditures of Jinling Pharmaceutical, 2012-2016
  • Major Controlled Hospitals of Jinling Pharmaceutical
  • Revenue and Net Income of Jinling Pharmaceutical, 2015-2020E
  • Revenue and Net Income of Shinva Medical Instrument, 2011-2016
  • Revenue Breakdown of Shinva Medical Instrument by Business, 2011-2016
  • Revenue Structure of Shinva Medical Instrument by Business, 2011-2016
  • Revenue Breakdown of Shinva Medical Instrument by Region, 2011-2016
  • Revenue Structure of Shinva Medical Instrument by Region, 2011-2016
  • Gross Margin of Shinva Medical Instrument by Business, 2011-2016
  • R&D Expenditures of Shinva Medical Instrument, 2012-2015
  • Medical Service Related Subsidiaries of Shinva Medical Instrument
  • Revenue and Net Income of Shinva Medical Instrument, 2015-2020E
  • Revenue and Net Income of Xi'an International Medical Investment, 2011-2016
  • Revenue Breakdown of Xi'an International Medical Investment by Business, 2012-2016
  • Revenue Structure of Xi'an International Medical Investment by Business, 2012-2016
  • Objects for Non-public Stock Issuance, Their Rationed Shares, and Subscription Amount of Xi'an International Medical Investment, 2015
  • Revenue and Net Income of Xi'an International Medical Investment, 2015-2020E
  • Revenue and Net Income of Inner Mongolia Furui Medical Science, 2011-2016
  • Revenue Breakdown of Inner Mongolia Furui Medical Science by Business, 2011-2016
  • Revenue Structure of Inner Mongolia Furui Medical Science by Business, 2011-2016
  • Revenue and Net Income of Inner Mongolia Furui Medical Science, 2015-2020E
  • Revenue and Net Income of Wuhan Jianmin Pharmaceutical Group, 2011-2016
  • Revenue Breakdown of Wuhan Jianmin Pharmaceutical Group by Business, 2012-2016
  • Revenue Structure of Wuhan Jianmin Pharmaceutical Group by Business, 2012-2016
  • Revenue and Net Income of Wuhan Jianmin Pharmaceutical Group, 2015-2020E
  • Revenue and Net Income of Concord Medical Services, 2012-2016
  • Service Network Coverage of Concord Medical Services
  • Revenue and Net Income of Phoenix Healthcare Group, 2011-2016
  • General Hospital Service Revenue of Phoenix Healthcare Group, 2011-2016
  • Hospital Management Service Revenue of Phoenix Healthcare Group by Hospital, 2014-2016
  • Revenue and Net Income of Phoenix Healthcare Group, 2015-2020E
  • Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2011-2016
  • Medical Service Revenue of Guizhou Yibai Pharmaceutical, 2011-2016
  • Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2015-2020E
  • Revenue and Net Income of Kangmei Pharmaceutical, 2011-2016
  • Revenue and Net Income of Kangmei Pharmaceutical, 2015-2020E
  • Revenue and Net Income of Jiangnan Mould & Plastic Technology, 2011-2016
  • Purpose of Funds Raised through Non-public Stock Issuance Plan of Jiangnan Mould & Plastic Technology, 2014
  • Revenue and Net Income of Jiangnan Mould & Plastic Technology, 2015-2020E
  • Revenue and Net Income of Beijing Meizhong Jiahe Hospital Management, 2013-2016
  • Sales from Top 5 Customers of Beijing Meizhong Jiahe Hospital Management, 2013-2015
  • Purpose of Funds Raised through Second Stock Issuance Scheme of Beijing Meizhong Jiahe Hospital Management, 2016
  • Revenue and Net Income of Beijing Meizhong Jiahe Hospital Management, 2015-2020E
Back to Top